Related Experiment Video

Updated: Jun 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

Rakesh K Sharma1, Vibhuti N Singh, Hanumanth K Reddy

  • 1Medical Center of South Arkansas, El Dorado, University of Arkansas for Medical Sciences, Little Rock, AR, USA. rk1965@gmail.com

Vascular Health and Risk Management
|October 9, 2009
PubMed

Insights

Statin therapy lowers LDL cholesterol but residual cardiovascular risk remains. Low HDL cholesterol and high triglycerides contribute significantly to this risk, impacting heart health.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Statin trials confirm LDL-C reduction benefits, yet residual cardiovascular risk persists.
  • Low high-density lipoprotein cholesterol (HDL-C) and high triglycerides (TG) are key contributors to this residual risk.
  • NCEP ATP III guidelines identify low HDL-C as an independent risk factor for coronary heart disease (CHD).

Purpose of the Study:

  • To explore the role of HDL-C and TG in residual cardiovascular risk.
  • To highlight the anti-atherogenic mechanisms of HDL-C.
  • To emphasize the clinical significance of non-HDL-C and TG reduction.

Main Methods:

  • Review of large statin trials and meta-analyses.
  • Analysis of epidemiological studies on HDL-C and CHD.
  • Examination of the relationship between TG, HDL-C, non-HDL-C, and cardiovascular outcomes.

Main Results:

  • Statin therapy effectively reduces LDL-C but does not eliminate all cardiovascular risk.
  • Low HDL-C and high TG are independently associated with increased CHD risk.
  • HDL-C possesses anti-atherogenic properties, including cholesterol efflux from foam cells.
  • Non-HDL-C serves as an indicator for residual risk associated with high TG.

Conclusions:

  • Addressing low HDL-C and high TG is crucial for managing residual cardiovascular risk.
  • Therapeutic strategies targeting HDL-C and TG can further reduce cardiovascular events.
  • Monitoring non-HDL-C provides valuable insight into comprehensive lipid management.

Keywords:
coronary heart diseasehigh-density lipoprotein cholesterollow-density lipoprotein cholesterolstatins

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...